XML 30 R5.htm IDEA: XBRL DOCUMENT v2.3.0.15
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (Unaudited) (USD $)
In Thousands
9 Months Ended
Sep. 25, 2011
Sep. 26, 2010
CASH FLOWS FROM OPERATING ACTIVITIES  
Net income$ 6,998$ 2,165
Adjustments to reconcile net income to net cash provided by operating activities:  
Depreciation3,0483,343
Amortization of intangible assets538377
Stock-based compensation expense247144
Deferred compensation expense176181
Gain on sale of fixed assets and acquisition of business(263)(2,794)
Stock warrants revaluation(76)(192)
(Increase) decrease in cash surrender value of life insurance135(15)
Deferred financing amortization8341,117
Amortization of debt discount and bond costs72108
Interest paid-in-kind116487
Amortization of loss on interest rate swap agreements677238
Change in fair value of derivative financial instruments(106)14
Change in operating assets and liabilities, net of the effects of acquisitions:  
Trade receivables(12,047)(6,683)
Inventories(2,525)(5,428)
Prepaid expenses and other54761
Accounts payable and accrued liabilities11,5037,397
Payments on deferred compensation obligations(348)(312)
Net cash provided by operating activities9,526208
CASH FLOWS FROM INVESTING ACTIVITIES  
Capital expenditures(1,643)(1,065)
Proceeds from sale of property, equipment and facilities878,408
Business acquisitions(6,213)(5,690)
Insurance premiums paid(119)(43)
Net cash provided by (used in) investing activities(7,888)1,610
CASH FLOWS FROM FINANCING ACTIVITIES  
Long-term debt payments, net(3,463)(10,409)
Short-term debt borrowings, net1,0009,500
Proceeds from life insurance policy loans2,7360
Payment on termination of interest rate swap agreements(1,137)0
Payment of deferred financing/debt issuance costs(2,514)(45)
Proceeds from exercise of stock options210
Proceeds from exercise of warrants to purchase common stock20
Other0(21)
Net cash used in financing activities(3,355)(975)
Increase (decrease) in cash and cash equivalents(1,717)843
Cash and cash equivalents at beginning of year1,95760
Cash and cash equivalents at end of period$ 240$ 903